Weekly News and Notes
From the Duke Global Health Institute
Greetings!
Duke Global Health Institute Members have been in the news this week with a variety of powerful stories.
First, don't miss the New York Times story on women affected by fistula in Tanzania and the Duke physician who is working to improve their condition and change their lives.
Second, DGHI Member Kevin Schulman publishes an insightful report in the New England Journal of Medicine about the increasing number of clinical trials being conducted overseas.
Finally, if you missed last week's Managing Toxic Risks for Global Health symposium, view the PowerPoint presentations from several speakers and read a summary of the proceedings below.
Until next week,
Geelea Seaford and Everyone at DGHI |
|
After a Devastat ing Birth Injury, Hope
In January, Denise Grady of the New York Times joined Dr. Jeff Wilkinson, DGHI member and Duke physician, and his team from Kilimanjaro Christian Medical Centre on a weeklong visit to Dodoma, Tanzania, to treat women suffering from fistula. Fistula is caused by an obstructed birth passage and can only be corrected through surgery. Two doctors hoped to perform 20 surgeries over a four day time period their journey and the women they helped. Read the compelling story of hope here
Listen to an interview with Dr. Jeff Wilkinson on Friday at noon on WUNC's The State of Things with Frank Stasio ( www.wunc.org) |
News and Announcements
Symposium offers interventions for managing toxic risks and improving global health
Alarmed by the danger of chemical exposures around the world, a distinguished and multidisciplinary group of scholars and government leaders gathered at Duke University on February 20th. The event, Managing Toxic Risks for Global Health Symposium, was hosted by the Integrated Toxicology and Environmental Health Program (ITEHP), the Superfund Basic Research Program and the Duke Global Health Institute (DGHI). Read more and View PowerPoint slideshows from the lineup of interesting speakers.
DGHI Member Kevin Schulman questions ethics of conducting clinical trials overseas in New England Journal of Medicine report
Top-tier U.S.-based pharmaceutical companies are moving their clinical trials overseas at warp speed, raising questions about ethics, quality control, and even the scientific value of their findings for people back in the U.S. "The FDA is supposed to provide oversight for such trials, but it simply wasn't designed to handle this kind of situation," says Kevin Schulman, MD, the senior author of the report appearing in the New England Journal of Medicine. Schulman says the number of Food and Drug Administration investigators based outside the U.S. has grown by 15 percent every year since 2002, while the number of U.S.-based investigators has fallen just over 5 percent during the same period. Read more
Center for Health Policy is on the move
The Center for Health Policy has moved to Erwin Terrace Office Complex at 2812 Erwin Road Suite 403, Durham. The new phone number is 919-613-5430.
|
|
Faculty Opportunities
* * *
Visit our website for more faculty funding opportunities. | |
|
|
|
Second Annual Blue Jean Ball
March 4, 2009 » 5-6:30 pm
Love Auditorium, LSRC
Provost Lecture Series
Thomas Shapiro, Brandeis
Poverty and Wealth Building
March 4, 2009 » 4:30 - 6:00 pm
John Hope Franklin Center - Room 240
University Seminar on Global Health:
Lawrence Gostin, Georgetown University, Meeting the Survival Needs of the World's Least Healthy People
* * *
Click for more global health events |
Visit Us at:
-  YouTubeU
- or On the Web
| |
